Stay updated on IBI310 Combo vs Sorafenib in HCC Clinical Trial
Sign up to get notified when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.

Latest updates to the IBI310 Combo vs Sorafenib in HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new Revision: v3.3.3 entry was added to the Record History, and the HHS Vulnerability Disclosure link along with the Revision: v3.3.2 entry were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe Record History now includes a new revision entry (v3.3.2) with the prior revision (v3.3.1) in the version list; this is a maintenance update and does not affect study data or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision history shows a new version (v3.3.1) added and an older version (v3.2.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRemoved the banner notice about a lapse in government funding that warned users about potential data delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check59 days agoChange Detected- The two screenshots reveal no substantive updates to the study history data; only minor UI labeling and layout variations are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check87 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference12%

Stay in the know with updates to IBI310 Combo vs Sorafenib in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 Combo vs Sorafenib in HCC Clinical Trial page.